ELMDElectromed, Inc.
- Analyst Upgrades
Lake Street Maintains Buy on Electromed, Raises Price Target to $47
Lake Street analyst Benjamin Haynor maintains Electromed with a Buy and raises the price target from $36 to $47. ...
- Earnings Call Transcripts
Electromed Fiscal Q4 2026 Earnings Call - ELECTROMED INC
Greetings and welcome to the ElectroMed Fiscal Q4 2026 earnings call. At this time, all participants are in a listen-only mode. The question and answer session will follow the formal presentation. If anyone should requir ...
- BusinessWire
Electromed Announces CEO’s Planned Retirement
Electromed, Inc. (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff expects to retire as President and Chief Executive Officer, on or about April 2, 2027. Upon his ...
- BusinessWire
Electromed, Inc. Announces Record Fiscal 2026 Fourth Quarter and Full Year Financial Results
Strong homecare revenue growth and expanded operating leverage drive record operating income in Fiscal 2026 Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, ...
- BusinessWire
Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal ...
- Analyst Upgrades
B. Riley Securities Maintains Buy on Electromed, Raises Price Target to $40
B. Riley Securities analyst Kyle Bauser maintains Electromed with a Buy and raises the price target from $38 to $40. ...
- Earnings Call Transcripts
Electromed Fiscal Q3 2026 Earnings CallELECTROMED INC
Greetings, and welcome to the ElectroMed Fiscal Q3 2026 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. If anyone requires opera ...
- BusinessWire
Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Third Quarter
18% Revenue growth and strong operating leverage exceeds consensus expectations for the third quarter of fiscal 2026 Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, ...
- BusinessWire
Electromed, Inc. to Report Q3 Fiscal 2026 Financial Results on May 12, 2026
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 third ...
- Earnings Call Transcripts
38TH ANNUAL ROTH CONFERENCEELECTROMED INC
Okay, good morning and thank you for joining us for our 38th Annual Roth Conference. My name is Kyle Bowser. I'm a Senior Research Analyst at Roth covering the medical device sector. Today we have Electromed, the CEO Jim ...
- Earnings Call Transcripts
Electromed Second Quarter Fiscal Year 2026 Earnings Conference Call - Electromed
Good day and welcome to the ElectroMed Second Quarter Fiscal Year 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing ...
- BusinessWire
Electromed, Inc. Announces Record Financial Performance in Fiscal 2026 Second Quarter
Strong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, ...
- BusinessWire
Electromed, Inc. to Report Q2 Fiscal 2026 Financial Results on February 10, 2026
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 second ...
- Analyst Upgrades
Roth Capital Reiterates Buy on Electromed, Raises Price Target to $36
Roth Capital analyst Kyle Bauser reiterates Electromed with a Buy and raises the price target from $35 to $36. ...
- BusinessWire
Electromed, Inc. Announces First Quarter Fiscal 2026 Results
Strong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, ...
- BusinessWire
Electromed, Inc. to Report Q1 Fiscal 2026 Financial Results on November 12, 2025
Electromed, Inc. ("Electromed" or the "Company") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2026 first ...
- SEC
ARS Form - Annual Report to Security Holders - Electromed, Inc. (0001488917) (Filer)
Annual Report to Security Holders ...
- SEC
DEF 14A Form - Other definitive proxy statements - Electromed, Inc. (0001488917) (Filer)
Other definitive proxy statements ...
- SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Electromed, Inc. (0001488917) (Filer)
Additional definitive proxy soliciting materials and Rule 14(a)(12) material ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - Electromed, Inc. (0001488917) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
144 Form - Report of proposed sale of securities - Electromed, Inc. (0001488917) (Subject)
Report of proposed sale of securities ...
- SEC
8-K Form - Current report, items 7.01, 8.01, and 9.01 - Electromed, Inc. (0001488917) (Filer)
Current report, items 7.01, 8.01, and 9.01 ...
- BusinessWire
Electromed, Inc. Announces Share Repurchase Authorization
Electromed, Inc. ("Electromed") (NYSE:ELMD), a leader in innovative airway clearance technologies, today announced that on September 9, 2025, its Board of Directors authorized Electromed to repurchase up to $10.0 ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - Electromed, Inc. (0001488917) (Issuer)
Statement of changes in beneficial ownership of securities ...
- SEC
4 Form - Statement of changes in beneficial ownership of securities - Electromed, Inc. (0001488917) (Issuer)
Statement of changes in beneficial ownership of securities ...